| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 43.247 | 93.283 | 130.398 | 211.522 | 234.462 |
| Total Income - EUR | - | - | - | - | - | 43.261 | 93.283 | 130.768 | 211.531 | 235.895 |
| Total Expenses - EUR | - | - | - | - | - | 41.788 | 90.986 | 122.775 | 176.163 | 217.409 |
| Gross Profit/Loss - EUR | - | - | - | - | - | 1.473 | 2.296 | 7.994 | 35.368 | 18.486 |
| Net Profit/Loss - EUR | - | - | - | - | - | 1.218 | 1.401 | 6.840 | 33.668 | 16.036 |
| Employees | - | - | - | - | - | 1 | 1 | 1 | 1 | 2 |
Check the financial reports for the company - Triomedical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 181 | 108 | 5.917 | 19.159 | 25.153 |
| Current Assets | - | - | - | - | - | 15.419 | 24.314 | 23.238 | 36.993 | 35.084 |
| Inventories | - | - | - | - | - | 13.456 | 23.965 | 21.343 | 22.498 | 30.014 |
| Receivables | - | - | - | - | - | 622 | 332 | 843 | 6.229 | 1.421 |
| Cash | - | - | - | - | - | 1.341 | 16 | 1.052 | 8.266 | 3.650 |
| Shareholders Funds | - | - | - | - | - | 1.259 | 2.632 | 9.480 | 33.716 | 43.448 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 14.340 | 21.789 | 16.061 | 21.433 | 30.062 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 3.615 | 3.604 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Triomedical S.r.l.